We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 9,778 results
  1. Long-term outcomes of busulfan plus melphalan-based versus melphalan 200 mg/m2 conditioning regimens for autologous hematopoietic stem cell transplantation in patients with multiple myeloma: a systematic review and meta-analysis

    Background

    High-dose melphalan (HDMEL, 200 mg/m 2 ) is considered as the standard conditioning regimen for autologous hematopoietic stem cell...

    Fei Gao, Mei-Si Lin, ... Qi-Yan Chen in Cancer Cell International
    Article Open access 10 November 2021
  2. Effect of Application of Autologous Conditioned Serum on Wound Healing in Diabetic Mice Through Inhibition of STING Pathway Activation

    Slow wound healing in diabetic patients is a common complication of diabetes. Autologous conditioned serum (ACS) therapy is an emerging and safe...

    Hongxia Li in Biochemical Genetics
    Article 13 March 2024
  3. Evaluation of hiPSC-Derived Muscle Progenitor Cell Transplantation in a Mouse Duchenne Muscular Dystrophy Model

    For cell therapy toward Duchenne muscle dystrophy (DMD), muscle progenitor cells derived from human-induced pluripotent stem cell (hiPSC-MuPCs) are...
    Minas Nalbandian, Mingming Zhao, Hidetoshi Sakurai in Muscular Dystrophy Therapeutics
    Protocol 2023
  4. Tolerance and Transplantation Immunology

    In this chapter, we will first discuss about the impact and mechanisms of immunological tolerance, which is differentiated into central and...
    Carsten Carlberg, Eunike Velleuer in Molecular Immunology
    Chapter 2022
  5. Synthesis of siRNA-Conjugated Dextran-Coated Iron Oxide Nanoparticles for Islet Protection During Transplantation and Noninvasive Imaging

    Pancreatic islet transplantation (Tx) has a lifesaving potential for type 1 diabetes (T1D) patients. Islet damage during and after transplantation is...
    Neil Robertson, ** Wang, ... Anna Moore in Type-1 Diabetes
    Protocol 2023
  6. Dose-Dependent Effects of Intravenous Mesenchymal Stem Cell Transplantation in Rats with Acute Focal Cerebral Ischemia

    Intravenous transplantation of mesenchymal stem (stromal) cells (MSC) is a promising approach to the treatment of ischemic stroke. In the published...

    E. A. Cherkashova, D. D. Namestnikova, ... K. N. Yarygin in Bulletin of Experimental Biology and Medicine
    Article 01 August 2022
  7. Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure

    Magnesium is an essential element that is involved in critical metabolic pathways. A diet deficient in magnesium is associated with an increased risk...

    Jennifer J. Gile, Camden L. Lopez, ... Thomas E. Witzig in Blood Cancer Journal
    Article Open access 26 March 2021
  8. Linking gastrointestinal microbiota and metabolome dynamics to clinical outcomes in paediatric haematopoietic stem cell transplantation

    Background

    Haematopoietic stem cell transplantation is a curative procedure for a variety of conditions. Despite major advances, a plethora of adverse...

    Gintare Vaitkute, Gordana Panic, ... Mona Bajaj-Elliott in Microbiome
    Article Open access 10 June 2022
  9. Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease

    Metabolic diseases, including obesity, diabetes, and nonalcoholic fatty liver disease (NAFLD), are rising in both incidence and prevalence and remain...

    Yifei Chen, Fuji Yang, ... Jianhua ** in Journal of Translational Medicine
    Article Open access 22 October 2022
  10. Prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation comparing tuberculin skin test and interferon-gamma release assay

    The aim of this study was to evaluate the prevalence of latent Mycobacterium tuberculosis infection in hematopoietic stem cell transplantation...

    Victor A C Castro-Lima, Ana Paula T Santos, ... Silvia F Costa in European Journal of Clinical Microbiology & Infectious Diseases
    Article 01 May 2023
  11. Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective

    Abstract

    Autologous stem cell transplantation (ASCT) is a well-established approach to treatment of patients with relapsed/refractory (R/R) Hodgkin...

    Anna Sureda, Marc André, ... Jan Walewski in BMC Cancer
    Article Open access 10 November 2020
  12. The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant

    Upfront autologous stem cell transplant (ASCT) is the standard of care for newly diagnosed multiple myeloma (MM) patients. However, relapse is...

    Saurabh Zanwar, Eapen K. Jacob, ... Taxiarchis Kourelis in Blood Cancer Journal
    Article Open access 26 September 2023
  13. Fecal Microbiota Transplantation as Emerging Treatment in European Countries 2.0

    Clostridioides difficile infection (CDI) is one of the most common healthcare-associated infections and one of the leading causes of morbidity and...
    Serena Porcari, Marcello Maida, ... Giovanni Cammarota in Updates on Clostridioides difficile in Europe
    Chapter 2024
  14. Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis

    The present study evaluated outcomes and prognostic factors in adult patients with acute myeloid leukemia (AML) after syngeneic hematopoietic stem...

    Shuhei Kurosawa, Shohei Mizuno, ... Masamitsu Yanada in Blood Cancer Journal
    Article Open access 24 September 2021
  15. Transplantation of mesenchymal stem cells for spinal cord injury: a systematic review and network meta-analysis

    Spinal cord injury (SCI) is a severe traumatic disease of the central nervous system, with a global prevalence of 236–4187 per million people. This...

    Wei-can Chen, Wei-feng Liu, ... He-fan He in Journal of Translational Medicine
    Article Open access 28 April 2021
  16. Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation

    Microbiota are essential to normal immune development and there is growing recognition of its importance to human health and disease and deepening...

    Matthew J. Pianko, Jonathan L. Golob in Cancer and Metastasis Reviews
    Article 29 April 2022
  17. Drivers and determinants of strain dynamics following fecal microbiota transplantation

    Fecal microbiota transplantation (FMT) is a therapeutic intervention for inflammatory diseases of the gastrointestinal tract, but its clinical mode...

    Thomas S. B. Schmidt, Simone S. Li, ... Peer Bork in Nature Medicine
    Article Open access 15 September 2022
Did you find what you were looking for? Share feedback.